MDL 62873

Known as: MDL-62873, Ristomycin A aglycone, 34-O-(2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl)-22,31-dichloro-38-de(methoxycarbonyl)-7-demethyl-19-deoxy-56-O-(2-deoxy-2-((8-methyl-1-oxononyl)amino)-beta-D-glucopyranosyl)-38-(((3-(dimethylamino)propyl)amino)carbonyl)-42- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Four novel glycopeptide antibiotics, namely MDL 62708, MDL 63155, MDL 62827, MDL 62873 (mideplanin), plus teicoplanin, which… (More)
Is this relevant?
1993
1993
In vitro response of 469 clinical isolates of gram-positive cocci was tested against MDL 62873 by the agar dilution method. The… (More)
Is this relevant?
1992
1992
MDL 62208, MDL 62211, and MDL 62873 are three semisynthetic amide derivatives of teicoplanin (MDL 62208 is an amide of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1992
1992
The minimum inhibitory concentrations (MICs) of ten antibiotics were determined by the agar dilution method for 40 strains of… (More)
Is this relevant?
1991
1991
MDL 62211 is the amide derivative of the teicoplanin complex and MDL 62873 is a more focused amide derivative of the teicoplanin… (More)
  • table 1
  • table 2
Is this relevant?
1990
1990
The minimum inhibitory concentrations (MICs) of different antibiotics were determined by a broth microdilution method for… (More)
Is this relevant?